DE69939335D1 - Dispergierbares konzentrat zur verabreichung von cyclosporin - Google Patents

Dispergierbares konzentrat zur verabreichung von cyclosporin

Info

Publication number
DE69939335D1
DE69939335D1 DE69939335T DE69939335T DE69939335D1 DE 69939335 D1 DE69939335 D1 DE 69939335D1 DE 69939335 T DE69939335 T DE 69939335T DE 69939335 T DE69939335 T DE 69939335T DE 69939335 D1 DE69939335 D1 DE 69939335D1
Authority
DE
Germany
Prior art keywords
surfactant
formulation
cyclosporin
administration
less
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69939335T
Other languages
English (en)
Inventor
Abraham J Domb
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dexcel Ltd Israel
Original Assignee
Dexcel Ltd Israel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dexcel Ltd Israel filed Critical Dexcel Ltd Israel
Application granted granted Critical
Publication of DE69939335D1 publication Critical patent/DE69939335D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
DE69939335T 1998-12-30 1999-12-30 Dispergierbares konzentrat zur verabreichung von cyclosporin Expired - Lifetime DE69939335D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22337898A 1998-12-30 1998-12-30
PCT/IL1999/000710 WO2000040219A1 (en) 1998-12-30 1999-12-30 Dispersible concentrate for the delivery of cyclosporin

Publications (1)

Publication Number Publication Date
DE69939335D1 true DE69939335D1 (de) 2008-09-25

Family

ID=22836258

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69939335T Expired - Lifetime DE69939335D1 (de) 1998-12-30 1999-12-30 Dispergierbares konzentrat zur verabreichung von cyclosporin

Country Status (12)

Country Link
US (1) US7026290B1 (de)
EP (1) EP1154759B1 (de)
JP (1) JP2002534370A (de)
AT (1) ATE404172T1 (de)
AU (1) AU769429C (de)
CA (1) CA2358448C (de)
DE (1) DE69939335D1 (de)
DK (1) DK1154759T3 (de)
IL (1) IL143604A0 (de)
NZ (1) NZ512599A (de)
PT (1) PT1154759E (de)
WO (1) WO2000040219A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9912476D0 (en) * 1999-05-28 1999-07-28 Novartis Ag Organic compounds
ES2241663T3 (es) * 1999-09-21 2005-11-01 Skyepharma Canada Inc. Composiciones particuladas modificadas superficialmente de substancias biologicamente activas.
AU2006201100B2 (en) * 1999-09-21 2009-09-24 Jagotec Ag Surface modified particulate compositions of biologically active substances
US7919113B2 (en) * 1999-12-30 2011-04-05 Yissum Research Development Company Of The Hebrew University Of Jerusalem Dispersible concentrate lipospheres for delivery of active agents
US7732404B2 (en) * 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
AUPR510001A0 (en) * 2001-05-18 2001-06-14 Jupitar Pty Ltd Formulation and method
MXPA04000014A (es) 2001-06-21 2004-05-21 Pfizer Prod Inc Formulaciones autoemulsionantes de inhibidores de la proteina de transferencia de colesteril ester.
AU2002952597A0 (en) * 2002-11-11 2002-11-28 Schering-Plough Pty. Limited Topical parasiticide formulations and methods of treatment
DE102006051512A1 (de) * 2005-12-06 2007-06-14 Pari GmbH Spezialisten für effektive Inhalation Pharmazeutische Medikamentenzusammensetzungen mit Cyclosporin
DE102006050026A1 (de) * 2006-10-13 2008-04-17 Bio Mac- Privatinstitut für medizinische und zahnmedizinische Forschung, Entwicklung und Diagnostik GmbH Verwendung von Verbindungen und pharmazeutische Zusammensetzung zur Suppression des Immunsystems
GB0623838D0 (en) * 2006-11-29 2007-01-10 Malvern Cosmeceutics Ltd Novel compositions
GB2451811A (en) * 2007-08-09 2009-02-18 Ems Sa Delivery composition for solubilising water-insoluble pharmaceutical active ingredients
MX2010003364A (es) 2007-10-08 2010-07-06 Lux Biosciences Inc Composiciones oftalmicas que comprenden inhibidores de calcineurina o inhibidores de mtor.
MX338355B (es) 2009-06-09 2016-04-13 Aurinia Pharmaceuticals Inc Sistemas de suministro de farmaco topico para uso oftalmico.
KR101586791B1 (ko) * 2012-12-28 2016-01-19 주식회사 종근당 GnRH 유도체의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
US20150352176A1 (en) * 2014-06-06 2015-12-10 Newport Research, Inc. Oil-free and fat-free aqueous suspensions of cyclosporin
US20200237859A1 (en) 2019-01-25 2020-07-30 Newport Research, Inc. Aqueous suspensions of cyclosporin
US11324800B2 (en) 2015-01-15 2022-05-10 Wellspring Ophthalmics, Inc. Aqueous suspensions of cyclosporin
US20190224275A1 (en) 2017-05-12 2019-07-25 Aurinia Pharmaceuticals Inc. Protocol for treatment of lupus nephritis

Family Cites Families (88)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4117118A (en) 1976-04-09 1978-09-26 Sandoz Ltd. Organic compounds
SE445174B (sv) 1978-03-07 1986-06-09 Sandoz Ag Farmaceutisk komposition innehallande en cyklosporin och en berarsubstans
US4215199A (en) 1978-06-05 1980-07-29 Sandoz Ltd. Antibiotic production
DE3167014D1 (en) 1980-02-14 1984-12-13 Sandoz Ag A method for the total synthesis of cyclosporins and novel cyclosporins
US5639724A (en) 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
US4861580A (en) 1985-10-15 1989-08-29 The Liposome Company, Inc. Composition using salt form of organic acid derivative of alpha-tocopheral
US5154930A (en) 1987-03-05 1992-10-13 The Liposome Company, Inc. Pharmacological agent-lipid solution preparation
KR880012221A (ko) 1987-04-13 1988-11-26 사노 가즈오 에스테르 또는 아미드를 활성성분으로 함유하는 약제 조성물
EP0296122B1 (de) 1987-06-17 1993-09-29 Sandoz Ag Cyclosporine und deren Benutzung als Arzneimittel
US5756450A (en) 1987-09-15 1998-05-26 Novartis Corporation Water soluble monoesters as solubilisers for pharmacologically active compounds and pharmaceutical excipients and novel cyclosporin galenic forms
US4994267A (en) 1988-03-04 1991-02-19 Noven Pharmaceuticals, Inc. Transdermal acrylic multipolymer drug delivery system
US4814168A (en) 1988-03-04 1989-03-21 Noven Pharmaceuticals, Inc. Transdermal multipolymer drug delivery system
GB8809616D0 (en) 1988-04-22 1988-05-25 Cancer Res Campaign Tech Further improvements relating to drug delivery systems
US5342625A (en) 1988-09-16 1994-08-30 Sandoz Ltd. Pharmaceutical compositions comprising cyclosporins
KR0148748B1 (ko) 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
SE8804164A0 (sv) 1988-11-17 1990-05-18 Per Prisell Farmaceutisk beredning
HU201577B (en) 1988-12-20 1990-11-28 Gyogyszerkutato Intezet Process for producing cyclosporin antibiotics
US5272068A (en) 1989-03-15 1993-12-21 Merck & Co., Inc. Process for producing immunosuppressant agent L-683942 by fermentation
DE69013189T2 (de) 1989-03-15 1995-05-11 Merck & Co Inc Verfahren zur Herstellung einer immunosuppressiven Substanz (demethimmunomycin) durch Verwendung eines Stamm-Mutanten eines Mikroorganismus.
US5188837A (en) 1989-11-13 1993-02-23 Nova Pharmaceutical Corporation Lipsopheres for controlled delivery of substances
US5227165A (en) 1989-11-13 1993-07-13 Nova Pharmaceutical Corporation Liposphere delivery systems for local anesthetics
IE904098A1 (en) 1989-11-13 1991-05-22 Nova Pharm Corp Lipospheres for controlled delivery of substances
US5178866A (en) 1990-03-23 1993-01-12 Alza Corporation Dosage form for delivering drug to the intestine
ATE148469T1 (de) 1990-11-02 1997-02-15 Sandoz Ag Zyklosporine
HU208491B (en) 1990-11-27 1993-11-29 Gyogyszerkutato Intezet Process for producing oral pharmaceutical composition containing cyclosporin
CA2101777A1 (en) 1991-01-25 1992-07-26 Toshio Goto Process for producing cyclosporin a and/or c
US5378475A (en) 1991-02-21 1995-01-03 University Of Kentucky Research Foundation Sustained release drug delivery devices
JP2721041B2 (ja) 1991-04-19 1998-03-04 ネクスター・フアーマシユーテイカルズ・インコーポレイテツド 医薬調合品及び方法
US5683714A (en) 1991-04-19 1997-11-04 Nexstar Pharmaceuticals, Inc. Liposomal cyclosporin pharmaceutical formulation
IL101007A (en) 1992-02-18 1997-08-14 Pharmos Ltd Dry stable compositions prepared by lyophilization
US5529785A (en) 1993-05-12 1996-06-25 Dietl; Hans Pharmaceutical preparation containing cyclosporin(s) for oral administration and process for producing same
US5637317A (en) 1992-05-18 1997-06-10 Dietl; Hans Pharmaceutical preparation containing cyclosporin(s) for oral administration and process for producing same
HU213553B (en) 1992-05-25 1997-07-28 Biogal Gyogyszergyar Process for isolating of cyclosporin-a
US5759566A (en) 1992-07-28 1998-06-02 Poli Industria Chimica Spa Microemulsion pharmaceutical compositions for the delivery of pharmaceutically active agents
SK278290B6 (en) 1992-09-07 1996-08-07 Milan Stuchlik Medicaments with n-methylated cyclic undecapeptides
FI92334C (fi) 1992-12-30 1994-10-25 Leiras Oy Menetelmä syklosporiinien tuottamiseksi ja menetelmässä käytettävä uusi Tolypocladium-kanta
ES2115231T3 (es) 1993-04-20 1998-06-16 Hexal Ag Emplasto con sustancias activas.
US5576016A (en) 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles
CH686761A5 (de) 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
US5639474A (en) 1993-07-01 1997-06-17 Hanmi Pharm. Ind., Ltd. Cyclosporin soft capsule composition
ES2308955T5 (es) 1993-09-28 2012-04-03 R.P. Scherer Gmbh Fabricación de cápsulas de gelatina blanda
DE4340781C3 (de) 1993-11-30 2000-01-27 Novartis Ag Cyclosporin enthaltende flüssige Zubereitungen und Verfahren zu ihrer Herstellung
WO1995020943A1 (en) * 1994-02-04 1995-08-10 Scotia Lipidteknik Ab Oil-in-water emulsions
US5891846A (en) 1994-02-17 1999-04-06 Shiseido Company, Ltd. Cyclosporin-containing emulsion composition
KR0146671B1 (ko) 1994-02-25 1998-08-17 김충환 사이클로스포린-함유 분말 조성물
GB9405304D0 (en) 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
US5430021A (en) 1994-03-18 1995-07-04 Pharmavene, Inc. Hydrophobic drug delivery systems
US5651980A (en) 1994-04-15 1997-07-29 Biohybrid Technologies, Inc. Methods of use of uncoated gel particles
JP2936209B2 (ja) 1994-06-01 1999-08-23 ユーハン コーポレーション サイクロスポリン含有組成物およびその製造方法
US5958458A (en) 1994-06-15 1999-09-28 Dumex-Alpharma A/S Pharmaceutical multiple unit particulate formulation in the form of coated cores
KR100304324B1 (ko) 1994-10-13 2001-11-22 김용규 사이클로스포린a의제조방법
KR0126610B1 (ko) 1994-10-18 1997-12-29 김충환 고생산 세포융합변이균주에 의한 사이클로스포린 a의 제조방법
US5603951A (en) 1994-11-09 1997-02-18 Hanmi Pharm. Ind. Co., Ltd. Cyclosporin-containing soft capsule compositions
DE4440337A1 (de) 1994-11-11 1996-05-15 Dds Drug Delivery Services Ges Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit
HU215966B (hu) 1994-11-21 1999-07-28 BIOGAL Gyógyszergyár Rt. Orálisan alkalmazható, ciklosporint tartalmazó, összetett emulzió-előkoncentrátum
KR0167613B1 (ko) 1994-12-28 1999-01-15 한스 루돌프 하우스, 니콜 케르커 사이클로스포린-함유 연질캅셀제 조성물
EP0725076B1 (de) 1995-02-01 2001-06-06 National Research Development Corporation of India Verfahren zur Gewinnung von Cyclosporin A aus einer Tolypocladiumspecies
US5573783A (en) 1995-02-13 1996-11-12 Nano Systems L.L.C. Redispersible nanoparticulate film matrices with protective overcoats
FI102758B (fi) 1995-03-03 1999-02-15 Santen Pharmaceutical Co Ltd Menetelmä puhtaan syklosporiinimuodon valmistamiseksi
IE75744B1 (en) 1995-04-03 1997-09-24 Elan Corp Plc Controlled release biodegradable micro- and nanospheres containing cyclosporin
AU692255B2 (en) 1995-04-24 1998-06-04 Yissum Research Development Company Of The Hebrew University Of Jerusalem Self-emulsifiable formulation producing an oil-in-water emulsion
US5716928A (en) 1995-06-07 1998-02-10 Avmax, Inc. Use of essential oils to increase bioavailability of oral pharmaceutical compounds
US5616595A (en) 1995-06-07 1997-04-01 Abbott Laboratories Process for recovering water insoluble compounds from a fermentation broth
US5665386A (en) 1995-06-07 1997-09-09 Avmax, Inc. Use of essential oils to increase bioavailability of oral pharmaceutical compounds
US5656287A (en) 1995-06-07 1997-08-12 Nexstar Pharmaceuticals, Inc. Liposomal cyclosporin formulations as agents for immunosuppression and multiple drug resistant indications
US5962019A (en) 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
US5827822A (en) 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
EP0760237A1 (de) 1995-08-30 1997-03-05 Cipla Limited Öl-in-Wasser-Mikroemulsionen
US5968972A (en) 1995-10-26 1999-10-19 Baker Norton Pharmaceuticals, Inc. Method for increasing the oral bioactivity of pharmaceutical agents
NZ280689A (en) 1995-12-15 1997-08-22 Bernard Charles Sherma Sherman Pharmaceutical composition comprising a cyclosporipharmaceutical composition comprising a cyclosporin; a tocol, tocopherol or tocotrienol; and propylen; a tocol, tocopherol or tocotrienol; and propylene carbonate or polyethylene glycol ne carbonate or polyethylene glycol
KR970064620A (ko) * 1996-03-05 1997-10-13 임성기 사이클로스포린-함유 외용약제 조성물
DE19611094C2 (de) 1996-03-21 1999-06-17 Dresden Arzneimittel Verfahren zur Reinigung von Cyclosporin A und/oder verwandten Cyclosporinen aus einem Cyclosporin-haltigen Rohextrakt unter Anwendung chromatographischer Verfahren mit Kieselgel als Adsorbens
IL117773A (en) 1996-04-02 2000-10-31 Pharmos Ltd Solid lipid compositions of coenzyme Q10 for enhanced oral bioavailability
US5660858A (en) 1996-04-03 1997-08-26 Research Triangle Pharmaceuticals Cyclosporin emulsions
US5709797A (en) 1996-06-05 1998-01-20 Poli Industria Chimica S.P.A. Method of isolating cyclosporins
US5747330A (en) 1996-06-05 1998-05-05 Poli Industria Chimica Antibiotic producing microbe
US5958876A (en) 1996-06-19 1999-09-28 Novartis Ag Cyclosporin-containing pharmaceutical compositions
US5958378A (en) 1996-07-03 1999-09-28 Research Development Foundation High dose liposomal aerosol formulations containing cyclosporin A or budesonide
KR980008239A (ko) 1996-07-26 1998-04-30 김충환 사이클로스포린-함유 약학적 조성물
US5798333A (en) 1996-09-17 1998-08-25 Sherman; Bernard C. Water-soluble concentrates containing cyclosporins
JP4718653B2 (ja) 1997-03-12 2011-07-06 アボツト・ラボラトリーズ シクロスポリンの投与のための親水性二成分系
US5891845A (en) 1997-11-21 1999-04-06 Fuisz Technologies Ltd. Drug delivery systems utilizing liquid crystal structures
US6028067A (en) 1997-12-05 2000-02-22 Chong Kun Dang Corp. Cyclosporin-containing microemulsion preconcentrate composition
ID25908A (id) * 1998-03-06 2000-11-09 Novartis Ag Prakonsentrat-prakonsentrat emulsi yang mengandung siklosporin atau makrolida
FR2780061B1 (fr) 1998-06-22 2001-09-07 Rhone Poulenc Rorer Sa Nouveau procede de preparation de derives de cyclosporine
US6267985B1 (en) 1999-06-30 2001-07-31 Lipocine Inc. Clear oil-containing pharmaceutical compositions
US6057289A (en) 1999-04-30 2000-05-02 Pharmasolutions, Inc. Pharmaceutical composition comprising cyclosporin in association with a carrier in a self-emulsifying drug delivery system
MXPA04000014A (es) * 2001-06-21 2004-05-21 Pfizer Prod Inc Formulaciones autoemulsionantes de inhibidores de la proteina de transferencia de colesteril ester.

Also Published As

Publication number Publication date
US7026290B1 (en) 2006-04-11
EP1154759A4 (de) 2005-07-20
JP2002534370A (ja) 2002-10-15
PT1154759E (pt) 2008-11-20
DK1154759T3 (da) 2008-12-08
ATE404172T1 (de) 2008-08-15
AU769429C (en) 2004-10-28
CA2358448C (en) 2009-02-10
EP1154759A1 (de) 2001-11-21
AU769429B2 (en) 2004-01-29
AU1796200A (en) 2000-07-24
IL143604A0 (en) 2002-04-21
CA2358448A1 (en) 2000-07-13
NZ512599A (en) 2003-10-31
WO2000040219A1 (en) 2000-07-13
EP1154759B1 (de) 2008-08-13

Similar Documents

Publication Publication Date Title
DE69939335D1 (de) Dispergierbares konzentrat zur verabreichung von cyclosporin
FR2710535B1 (fr) Composition à usage pharmaceutique ou cosmétique apte à former une microémulsion.
IT1281337B1 (it) Preparazione farmaceutica orale contenente ciclosporina come sostanza attiva ed un preconcentrato di emulsione multipla
NO20000467L (no) Farmasøytisk preparat i form av en selvemulgerende formulering for lipofile forbindelser
EP1072249A3 (de) Kosmetische und dermatologische Zubereitungen auf der Grundlage von O/W-Emulsionen
KR960021056A (ko) 사이클로스포린-함유 연질캅셀제 조성물
ZA973653B (en) Pharmaceutical compositions.
BR0210505A (pt) Formulações auto-emulsionantes de inibidores da proteìna de transferência de ésteres de colesterilo
KR870009720A (ko) 서방형 신규 제약 제제물
JPH08505367A (ja) 医薬用エマルジョン組成物
KR970064620A (ko) 사이클로스포린-함유 외용약제 조성물
AU2003248969A1 (en) Pharmaceutical formulation comprising cyclosporin, propylene glycol ester and non-ionic surfactant
EP1072247A3 (de) Kosmetische und dermatologische Zubereitungen auf der Grundlage von O/W-Emulsionen
KR970706803A (ko) 경구용 시클로스포린 제형(oral cyclosporin formulations)
EP0623287A1 (de) Essbare Mikroemulsionen aus Öl, Wasser, Alkoholen und Tensid
JPS6413020A (en) Diclofenac sodium-containing emulsion external preparation
DK0808154T3 (da) Formuleringer af forbindelser som nanopartikel-dispersioner i fordøjelige olier eller fedtsyrer
JPS56127308A (en) Blood-coagulation factor 8 pharmaceutical
JPS5653608A (en) Emulsified stick cosmetic
KR960030783A (ko) 수성 현탁액 형태의 살충제제
JPH06293617A (ja) 非水系洗浄剤組成物
RU2006100112A (ru) Трансназальные микроэмульсии, содержащие диазепам
JP2954852B2 (ja) 植物油の乳化性濃厚物を製造するための新規な乳化系
JPH0570793A (ja) 脂質の粒状組成物
JPH10330250A (ja) メナテトレノン油性製剤

Legal Events

Date Code Title Description
8364 No opposition during term of opposition